Inositol supplementation in premature infants with respiratory distress syndrome.

Inositol supplementation in respiratory distress syndrome.

Expression profile of plasma microRNAs in premature infants with respiratory distress syndrome.

Estimation of red blood cell volume in premature infants with and without respiratory distress syndrome.

Disordered pathways of fibrin turnover in lung lavage of premature infants with respiratory distress syndrome.

Inositol in preterm infants at risk for or having respiratory distress syndrome.

[Surfactant substitution in severe respiratory distress syndrome in premature infants weighing less than 1,000 g].

Pulmonary pseudocysts in newborn infants with respiratory distress syndrome.

Prognosis for infants with idiopathic respiratory distress syndrome.

Failure of indomethacin therapy to induce closure of patent ductus arteriosus in premature infants with respiratory distress syndrome.

A multicenter, randomized, double-blind trial of a new porcine surfactant in premature infants with respiratory distress syndrome.

Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study.

Current perspectives for management of acute respiratory insufficiency in premature infants with acute respiratory syndrome.

FiO2 predicts outcome in infants with respiratory syncytial virus-induced acute respiratory distress syndrome.

A clinical score for predicting the level of respiratory care in infants with respiratory distress syndrome.

The role of surfactant and non-invasive mechanical ventilation in early management of respiratory distress syndrome in premature infants.

Relationship between cortisol levels in umbilical cord plasma and development of the respiratory distress syndrome in premature newborn infants.

sphingomyelin ratio and fetal asphyxia to respiratory distress syndrome in premature infants.

Failure of association of premature rupture of membranes with respiratory-distress syndrome.

Does routine nursing care complicate the physiologic status of the premature neonate with respiratory distress syndrome?

Rachitic respiratory distress in small preterm infants.

Assessment of lung ventilation in infants with respiratory distress syndrome using electrical impedance tomography.

Delayed compliance increase in infants with respiratory distress syndrome following synthetic surfactant.

Poractant alfa versus beractant in the treatment of preterm infants with respiratory distress syndrome.

Evaluation of renal functions in preterm infants with respiratory distress syndrome.

Suggest Documents

Inositol supplementation in respiratory distress syndrome.

Expression profile of plasma microRNAs in premature infants with respiratory distress syndrome.

Estimation of red blood cell volume in premature infants with and without respiratory distress syndrome.

Disordered pathways of fibrin turnover in lung lavage of premature infants with respiratory distress syndrome.

Inositol in preterm infants at risk for or having respiratory distress syndrome.

[Surfactant substitution in severe respiratory distress syndrome in premature infants weighing less than 1,000 g].

Pulmonary pseudocysts in newborn infants with respiratory distress syndrome.

Prognosis for infants with idiopathic respiratory distress syndrome.

Failure of indomethacin therapy to induce closure of patent ductus arteriosus in premature infants with respiratory distress syndrome.

A multicenter, randomized, double-blind trial of a new porcine surfactant in premature infants with respiratory distress syndrome.

Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study.

Current perspectives for management of acute respiratory insufficiency in premature infants with acute respiratory syndrome.

FiO2 predicts outcome in infants with respiratory syncytial virus-induced acute respiratory distress syndrome.

A clinical score for predicting the level of respiratory care in infants with respiratory distress syndrome.

The role of surfactant and non-invasive mechanical ventilation in early management of respiratory distress syndrome in premature infants.

Relationship between cortisol levels in umbilical cord plasma and development of the respiratory distress syndrome in premature newborn infants.

sphingomyelin ratio and fetal asphyxia to respiratory distress syndrome in premature infants.

Failure of association of premature rupture of membranes with respiratory-distress syndrome.

Does routine nursing care complicate the physiologic status of the premature neonate with respiratory distress syndrome?

Rachitic respiratory distress in small preterm infants.

Assessment of lung ventilation in infants with respiratory distress syndrome using electrical impedance tomography.

Delayed compliance increase in infants with respiratory distress syndrome following synthetic surfactant.

Poractant alfa versus beractant in the treatment of preterm infants with respiratory distress syndrome.

Evaluation of renal functions in preterm infants with respiratory distress syndrome.

Inositol supplementation in premature infants with respiratory distress syndrome.

Recommend Documents

Follow Us